ARENTFOX SCHIFF LLP for CSL BEHRING
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Orphan drug tax exclusion in the Patient Protection and Affordable Care Act H.R. 3678 (Preserving Access to Orphan Drugs Act of 2015), all provisions, and its reintroduction
Foreign entity interest: CSL Limited, identified in the LD-1, is interested in U.S. health care policies that may affect the business of its subsidiary CSL Behring.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHILIP ENGLISH | — |
| NORMAN FREDERICK LENT | — |
| SONJA NESBIT | — |
Taxation/Internal Revenue Code TAX
Tax Reform legislation, including Border Adjustment Tax
Foreign entity interest: CSL Limited, identified in the LD-1, is interested in U.S. tax policies that may affect the business of its subsidiary CSL Behring.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHILIP ENGLISH | — |
| SONJA NESBIT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.